Yasuda, H., Hotta, N., Kasuga, M., Kashiwagi, A., Kawamori, R., Yamada, T., . . . Nakajo, K. (2015). Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study. J Diabetes Investig.

Yasuda, Hitoshi, Nigishi Hotta, Masato Kasuga, Atsunori Kashiwagi, Ryuzo Kawamori, Tadaaki Yamada, Yuko Baba, Levent Alev, and Ko Nakajo. "Efficacy and Safety of 40 mg or 60 mg Duloxetine in Japanese Adults With Diabetic Neuropathic Pain: Results From a Randomized, 52‐week, Open‐label Study." J Diabetes Investig 2015.

Yasuda, Hitoshi, et al. "Efficacy and Safety of 40 mg or 60 mg Duloxetine in Japanese Adults With Diabetic Neuropathic Pain: Results From a Randomized, 52‐week, Open‐label Study." J Diabetes Investig 2015.